Literature DB >> 27314567

Cortisol and Brain-Derived Neurotrophic Factor Levels Prior to Treatment in Children With Obsessive-Compulsive Disorder.

Şeref Şimşek1,2, Salih Gençoğlan3, Tuğba Yüksel2, İbrahim Kaplan4, Rümeysa Alaca2.   

Abstract

OBJECTIVE: In this study, we investigated serum brain-derived neurotrophic factor (BDNF), adrenocorticotropic hormone (ACTH), and cortisol levels between children with obsessive-compulsive disorder (OCD) prior to treatment and healthy controls. In addition, the study aimed to assess any correlations between OCD symptom severity and BDNF, ACTH, and cortisol levels.
METHODS: Twenty-nine children, aged from 7 to 17 years (male/female: 21/8) and diagnosed with OCD according to DSM-IV prior to treatment, were compared with 25 healthy control subjects (male/female: 16/9). The study was conducted between December 2012 and December 2013. The Kiddie Schedule for Affective Disorders and Schizophrenia, Present and Lifetime Version (K-SADS-PL), Children's Yale-Brown Obsessive Compulsive Scale, and Children's Depression Inventory (CDI) were administered to the children. BDNF, ACTH, and cortisol levels were detected using a prepared kit with the enzyme-linked immunosorbent assay method.
RESULTS: BDNF, ACTH, and cortisol levels in the OCD group were significantly higher when compared with the control group (P = .02, P = .03, and P = .046, respectively). No association was detected between the severity and duration of OCD symptoms and BDNF, ACTH, and cortisol levels. CDI scores in both groups were similar. The mean (SD) duration of OCD symptoms was 17.9 (18.5) months.
CONCLUSIONS: Our findings suggest that BDNF levels adaptively increase as a result of the damaging effects of the hypothalamic-pituitary-adrenal (HPA) axis hyperactivity on brain tissue in the early stages of OCD. HPA axis abnormalities and BDNF may play a role in the pathogenesis of the disease. © Copyright 2016 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27314567     DOI: 10.4088/JCP.15m10146

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  5 in total

1.  Cytokine, chemokine and BDNF levels in medication-free pediatric patients with obsessive-compulsive disorder.

Authors:  Rukiye Çolak Sivri; Ayhan Bilgiç; İbrahim Kılınç
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-01-04       Impact factor: 4.785

2.  Exploring Association Between Serotonin and Neurogenesis Related Genes in Obsessive-Compulsive Disorder in Chinese Han People: Promising Association Between DMRT2, miR-30a-5p, and Early-Onset Patients.

Authors:  Miaohan Deng; Yuan Wang; Shunying Yu; Qing Fan; Jianyin Qiu; Zhen Wang; Zeping Xiao
Journal:  Front Psychiatry       Date:  2022-05-13       Impact factor: 5.435

3.  Inflammatory dysregulation of monocytes in pediatric patients with obsessive-compulsive disorder.

Authors:  Natalia Rodríguez; Astrid Morer; E Azucena González-Navarro; Carles Serra-Pages; Daniel Boloc; Teresa Torres; Susana García-Cerro; Sergi Mas; Patricia Gassó; Luisa Lázaro
Journal:  J Neuroinflammation       Date:  2017-12-28       Impact factor: 8.322

Review 4.  The human BDNF gene: peripheral gene expression and protein levels as biomarkers for psychiatric disorders.

Authors:  A Cattaneo; N Cattane; V Begni; C M Pariante; M A Riva
Journal:  Transl Psychiatry       Date:  2016-11-22       Impact factor: 6.222

5.  Increased serum brain-derived neurotrophic factor and adrenocorticotropic hormone levels are associated with obsessive compulsive disorder in medication‑free children.

Authors:  Ayhan Bilgiç; Merve Sertdemir; İbrahim Kılınç; Ömer Faruk Akça
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-01-02       Impact factor: 4.785

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.